Filing Details
- Accession Number:
- 0000805928-25-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-11 16:22:36
- Reporting Period:
- 2025-06-10
- Filing Date:
- 2025-06-11
- Accepted Time:
- 2025-06-11 16:22:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 805928 | Axogen Inc. | AXGN | Electromedical & Electrotherapeutic Apparatus (3845) | 411301878 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1955281 | A. Joseph Tyndall | C/O Axogen, Inc. 13631 Progress Blvd., Suite 400 Alachua FL 32615 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-10 | 7,586 | $6.30 | 22,931 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-06-10 | 4,000 | $7.04 | 26,931 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-10 | 26,931 | $10.72 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | Disposition | 2025-06-10 | 7,586 | $6.30 | 7,586 | $6.30 |
| Common Stock | Employee Stock Option (right to purchase) | Disposition | 2025-06-10 | 4,000 | $7.04 | 4,000 | $7.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2033-09-01 | No | 4 | M | Direct | |
| 14,248 | 2034-06-06 | No | 4 | M | Direct |
Footnotes
- The reported price in Column 4 is a weighted average sale price. These shares were sold on June 10, 2025 in multiple transactions at prices ranging from $10.69 to $10.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Options vested on the first anniversary of the grant date, which was September 1, 2023.
- Options vested on the first anniversary of the grant date, which was June 6, 2024.
Billionaire Hedge Funds
